HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antidepressant-like effect of bright light is potentiated by L-serine administration in a mouse model of seasonal affective disorder.

Abstract
Bright light therapy is used as the primary treatment for seasonal affective disorder; however, the mechanisms underlying its antidepressant effect are not fully understood. Previously, we found that C57BL/6J mice exhibit increased depression-like behavior during a short-day condition (SD) and have lowered brain serotonin (5-HT) content. This study analyzed the effect of bright light on depression-like behaviors and the brain serotonergic system using the C57BL/6J mice. In the mice maintained under SD, bright light treatment (1000 lx, daily 1 h exposure) for 1 week reduced immobility time in the forced swimming test and increased intake of saccharin solution in a saccharin intake test. However, the light treatment did not modify 5-HT content and selective 5-HT uptake in the amygdala, or temporal patterns of core body temperature and wheel-running activity throughout a day. In the next experiment, we attempted to enhance the effect of bright light by using L-serine, a precursor of D-serine that acts as an N-methyl-D-aspartic acid receptor coagonist. Daily subcutaneous injection of L-serine for 2 weeks prior to the bright light strongly reduced the immobility time in the forced swimming test, suggesting a synergistic effect of light and L-serine. Furthermore, bright light increased the total number of 5-HT-immunoreactive cells and cells that had colocalized 5-HT and c-Fos immunosignals in several subregions of the raphe nuclei. These effects were potentiated by prior injection of L-serine. These data suggest that the bright light may elicit an antidepressant-like effect via enhanced 5-HT signals in the brain and L-serine can enhance these effects.
AuthorsMisato Kawai, Ryosei Goda, Tsuyoshi Otsuka, Ayaka Iwamoto, Nobuo Uotsu, Mitsuhiro Furuse, Shinobu Yasuo
JournalBrain research bulletin (Brain Res Bull) Vol. 118 Pg. 25-33 (Sep 2015) ISSN: 1873-2747 [Electronic] United States
PMID26340905 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Antidepressive Agents
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Serotonin
  • Serine
Topics
  • Animals
  • Antidepressive Agents (pharmacology)
  • Behavior, Animal (drug effects)
  • Brain (drug effects)
  • Disease Models, Animal
  • Fluoxetine (pharmacology)
  • Light
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Phototherapy (methods)
  • Random Allocation
  • Seasonal Affective Disorder (drug therapy, metabolism, therapy)
  • Serine (pharmacology)
  • Serotonin (metabolism)
  • Selective Serotonin Reuptake Inhibitors (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: